The acute myeloid leukemia 1 protein/protein ETO (AML1/ETO; A/E) fusion gene is responsible for 15% of AML cases and 15–26.7% of young patients with EMI. This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.